Article

Update to NCCN Guidelines on Infection

Author(s):

The National Comprehensive Cancer Network (NCCN) has added information on the H1N1 (swine flu) virus to its clinical practice guidelines on the Prevention and Treatment of Cancer-Related Infections.

The National Comprehensive Cancer Network (NCCN) has added information on the H1N1 (swine flu) virus to its clinical practice guidelines on the Prevention and Treatment of Cancer-Related Infections. In the section on treating lung infiltrates in patients with febrile neutropenia, the guidelines have been revised to note that some tests and antiviral treatments typically used for common strains of influenza and other respiratory viruses "may not be applicable" to the H1N1 strain and other pandemic strains.

The NCCN also added dorpenam (Doribax) to the Anctibacterial Agents Tables and tenofovir disoproxil fumarate (Viread) to the Antiviral Agents Tables. The updated guidelines are available at the NCCN Website, at NCCN.org.

Related Videos
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Jörn Schattenberg, MD | Credit: Novo Nordisk
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.